Aegis Lifesciences has full-fledged state of art R&D infrastructure, Equipment and Manpower including collaboration activities with reputes Scientific and health care institutions in India and abroad.
The R&D is well equipped to meet the requirements from Design, IPR, In-vitro testing, Design transfer meeting the highest standard of Regulatory requirements (ISO 13485: 2016 / Clause 7.2) / MRD, USFDA 510K and 21 CFR).
Aegis has been approved the DSIR accreditation (F.No. TU/ IV – RD/4698/2021) for its R&D Facility for the activities that had been undertaken in the past and for projects in future.
Some of the Key features and policies of R&D: